NLR and PLR Levels Following IPACK Block in Knee Arthroplasty

NCT06304298 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Knee Arthropathy
Knee Osteoarthritis
Knee Pain Chronic

Interventions

DRUG: 0.9% Sodium Chloride Injection
DRUG: Ropivacaine 0.2% Injectable Solution

Sponsor

Poznan University of Medical Sciences